electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

Company Overview - electroCore, Inc. is a commercial-stage bioelectronic medicine and wellness company focused on improving health through non-invasive vagus nerve stimulation technology [6] - Spark Biomedical, Inc. is a medical device developer specializing in wearable neurostimulation solutions for addiction treatment and other health issues [3][4] Partnership Announcement - electroCore will distribute the Sparrow Ascent™ device by Spark Biomedical within certain Department of Veterans Affairs (VA) facilities, aimed at treating opioid withdrawal symptoms [1][2] - This partnership is expected to enhance access to clinically validated, FDA-cleared, non-invasive treatment options for veterans [2] Product Details - Sparrow Ascent™ is a non-invasive transcutaneous auricular neuromodulation device designed to alleviate opioid withdrawal symptoms [1] - The device is available by prescription and represents a drug-free, wearable therapy option for patients [2] Market Strategy - electroCore is expanding its commercial sales organization and is actively seeking unique therapies to complement its existing product offerings [2] - The company believes that the Sparrow Ascent therapy will be well-received by customers familiar with neuromodulation devices like gammaCore™ [2]